Bokf Na Acquires New Shares in Hims & Hers Health, Inc. (NYSE:HIMS)

BOKF NA acquired a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 15,365 shares of the company's stock, valued at approximately $390,000.

A number of other hedge funds have also recently bought and sold shares of HIMS. Means Investment CO. Inc. lifted its stake in Hims & Hers Health by 23.5% in the fourth quarter. Means Investment CO. Inc. now owns 50,040 shares of the company's stock valued at $1,210,000 after buying an additional 9,508 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of Hims & Hers Health in the 4th quarter valued at approximately $18,048,000. State of Alaska Department of Revenue bought a new position in Hims & Hers Health during the 4th quarter worth approximately $2,628,000. Pacer Advisors Inc. acquired a new position in Hims & Hers Health during the fourth quarter valued at approximately $374,000. Finally, Louisiana State Employees Retirement System bought a new stake in Hims & Hers Health in the fourth quarter valued at approximately $2,234,000. 63.52% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the stock. Needham & Company LLC restated a "buy" rating and issued a $61.00 price objective on shares of Hims & Hers Health in a research report on Tuesday, May 6th. Bank of America raised their price target on Hims & Hers Health from $22.00 to $26.00 and gave the stock an "underperform" rating in a research report on Tuesday, April 29th. Morgan Stanley decreased their price objective on Hims & Hers Health from $60.00 to $40.00 and set an "equal weight" rating for the company in a research report on Tuesday, April 29th. Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Hims & Hers Health in a report on Wednesday. Finally, Citigroup reissued a "sell" rating and set a $30.00 price objective (up previously from $25.00) on shares of Hims & Hers Health in a research report on Tuesday, May 6th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $37.67.

Insiders Place Their Bets

In related news, CFO Oluyemi Okupe sold 11,581 shares of the business's stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $43.01, for a total value of $498,098.81. Following the completion of the sale, the chief financial officer now directly owns 107,789 shares in the company, valued at approximately $4,636,004.89. The trade was a 9.70 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Irene Becklund sold 2,203 shares of the firm's stock in a transaction on Thursday, April 3rd. The stock was sold at an average price of $28.78, for a total value of $63,402.34. Following the transaction, the insider now owns 8,007 shares in the company, valued at approximately $230,441.46. This trade represents a 21.58 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 650,500 shares of company stock worth $25,790,311 over the last three months. Insiders own 13.71% of the company's stock.

Hims & Hers Health Stock Performance

NYSE:HIMS traded up $0.64 during mid-day trading on Friday, hitting $52.04. The stock had a trading volume of 61,754,901 shares, compared to its average volume of 18,348,268. Hims & Hers Health, Inc. has a twelve month low of $12.07 and a twelve month high of $72.98. The stock has a market cap of $11.65 billion, a price-to-earnings ratio of 118.28 and a beta of 1.84. The company's 50 day simple moving average is $32.97 and its 200 day simple moving average is $32.43.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $0.20 earnings per share for the quarter, beating analysts' consensus estimates of $0.12 by $0.08. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. The business had revenue of $586.01 million for the quarter, compared to analysts' expectations of $535.21 million. During the same quarter in the prior year, the business earned $0.05 EPS. The firm's revenue for the quarter was up 110.7% on a year-over-year basis. As a group, equities analysts forecast that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.